Stockreport

Portola Pharmaceuticals Receives $100 Million Milestone Payment from HealthCare Royalty Partners for FDA Approval of Andexxa®

PORTOLA PHARMACEUTICALS  (PTLA) 
Last portola pharmaceuticals earnings: 2/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.portola.com
PDF SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the company has received a $100 million [Read more]